Enteric bisacodine soft gel capsule

By using enteric polymer soft gel capsules in capsule dosage forms, the problem of premature release of drugs in the stomach is solved, achieving delayed release and improved bioavailability.

CN119343137APending Publication Date: 2025-01-21R P SCHERER TECH INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380046106.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-06-13
Filing Date
2023-06-12
Publication Date
2025-01-21

Smart Images

  • Figure BDA0005179280590000221
    Figure BDA0005179280590000221
  • Figure BDA0005179280590000231
    Figure BDA0005179280590000231
  • Figure BDA0005179280590000232
    Figure BDA0005179280590000232
Patent Text Reader

Abstract

A soft gel capsule comprises a filler material and a shell composition wherein the filler composition comprises bisacodine and the shell composition comprises a film-forming material and an enteric polymer. The soft gel capsule further comprises 5 parts by weight of bisacodine based on 100 parts by weight of the filling material. A method of making a soft gel capsule using gel conversion is also provided.
Need to check novelty before this filing date? Find Prior Art